Chiu, H.-Y. (2015) “Risk Factor Analysis for the Immunogenicity of Adalimumab Associated with Decreased Clinical Response in Chinese Patients with Psoriasis”, Acta Dermato-Venereologica, 95(6), pp. 711–716. doi: 10.2340/00015555-2069.